The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia.
The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia.
复制标题
DOI:
10.1186/s12941-021-00462-7
复制
发表时间:
2021-08-24
影响因子:
5.7
通讯作者:
Xing X
中科院分区:
文献类型:
--
作者:
Chen L;Han X;Li Y;Zhang C;Xing X
To explore disease severity and risk factors for 30-day mortality of adult immunocompromised (IC) patients hospitalized with influenza-related pneumonia (Flu-p). A total of 122 IC and 1191 immunocompetent patients hospitalized with Flu-p from January 2012 to December 2018 were recruited retrospectively from five teaching hospitals in China. After controlling for confounders, multivariate logistic regression analysis showed that immunosuppression was associated with increased risks for invasive ventilation [odds ratio: (OR) 2.475, 95% confidence interval (CI): 1.511–4.053, p < 0.001], admittance to the intensive care unit (OR: 3.247, 95% CI 2.064–5.106, p < 0.001), and 30-day mortality (OR: 3.206, 95% CI 1.926–5.335, p < 0.001) in patients with Flu-p. Another multivariate logistic regression model revealed that baseline lymphocyte counts (OR: 0.993, 95% CI 0.990–0.996, p < 0.001), coinfection (OR: 5.450, 95% CI 1.638–18.167, p = 0.006), early neuraminidase inhibitor therapy (OR 0.401, 95% CI 0.127–0.878, p = 0.001), and systemic corticosteroid use at admission (OR: 6.414, 95% CI 1.348–30.512, p = 0.020) were independently related to 30-day mortality in IC patients with Flu-p. Based on analysis of the receiver operating characteristic curve (ROC), the optimal cutoff for lymphocyte counts was 0.6 × 109/L [area under the ROC (AUROC) = 0.824, 95% CI 0.744—0.887], sensitivity: 97.8%, specificity: 73.7%]. IC conditions are associated with more severe outcomes in patients with Flu-p. The predictors for mortality that we identified may be valuable for the management of Flu-p among IC patients. The online version contains supplementary material available at 10.1186/s12941-021-00462-7.
登录
查看更多内容
影响因子:
4.4
作者:
Muthuri SG;Venkatesan S;Myles PR;Leonardi-Bee J;Lim WS;Al Mamun A;Anovadiya AP;Araújo WN;Azziz-Baumgartner E;Báez C;Bantar C;Barhoush MM;Bassetti M;Beovic B;Bingisser R;Bonmarin I;Borja-Aburto VH;Cao B;Carratala J;Cuezzo MR;Denholm JT;Dominguez SR;Duarte PA;Dubnov-Raz G;Echavarria M;Fanella S;Fraser J;Gao Z;Gérardin P;Giannella M;Gubbels S;Herberg J;Higuera Iglesias AL;Hoeger PH;Hoffmann M;Hu X;Islam QT;Jiménez MF;Kandeel A;Keijzers G;Khalili H;Khandaker G;Knight M;Kusznierz G;Kuzman I;Kwan AM;Lahlou Amine I;Langenegger E;Lankarani KB;Leo YS;Linko R;Liu P;Madanat F;Manabe T;Mayo-Montero E;McGeer A;Memish ZA;Metan G;Mikić D;Mohn KG;Moradi A;Nymadawa P;Ozbay B;Ozkan M;Parekh D;Paul M;Poeppl W;Polack FP;Rath BA;Rodríguez AH;Siqueira MM;Skręt-Magierło J;Talarek E;Tang JW;Torres A;Törün SH;Tran D;Uyeki TM;van Zwol A;Vaudry W;Velyvyte D;Vidmar T;Zarogoulidis P;PRIDE Consortium Investigators;Nguyen-Van-Tam JS
通讯作者:
Nguyen-Van-Tam JS
影响因子:
4.4
作者:
Boonnak, Kobporn;Vogel, Leatrice;Subbarao, Kanta
通讯作者:
Subbarao, Kanta
影响因子:
5.2
作者:
Guo, Lingxi;Wei, Dong;Qu, Jieming
通讯作者:
Qu, Jieming
DOI:
10.1016/j.eimc.2012.02.007
发表时间:
2012-12-01
影响因子:
2.5
作者:
Lopez-Aldeguer, Jose;Iribarren, Jose A.;Lozano, Fernando
通讯作者:
Lozano, Fernando
影响因子:
11.8
作者:
Katzen, Jeremy;Kohn, Rachel;Ison, Michael G.
通讯作者:
Ison, Michael G.